🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Tapentadol is FDA approved for the treatment of moderate to severe acute pa...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2011-05
Trial ID
NCT01500317
Treatments Being Tested
The purpose of this study is to compare the risk of shopping behavior of ta...
Status
Completed
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT01545778
Treatments Being Tested
MOR-NRI like Tapentadol are expected to reduce signs and symptoms of centra...
Status
Terminated
Location
Department of Neurology
Start Date
2012-10
Trial ID
NCT01615510
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy of at least 1 dose...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01516008
Treatments Being Tested
The purpose of this study is to evaluate in patients who are eligible for e...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00361582
Treatments Being Tested
The purpose of this study is to evaluate the analgesic efficacy and safety ...
Status
Completed
Location
Multiple Locations
Start Date
2013-01
Trial ID
NCT01813890
Treatments Being Tested
The main objective of the study is to evaluate the effectiveness, tolerabil...
Status
Completed
Location
Site 1
Start Date
2009-09
Trial ID
NCT00983073
Treatments Being Tested
The main objective of the study is to evaluate the effectiveness, tolerabil...
Status
Terminated
Location
Site 4
Start Date
2009-09
Trial ID
NCT00982280
Treatments Being Tested
The main objective of the study is to evaluate the effectiveness, tolerabil...
Status
Completed
Location
Site 5
Start Date
2009-09-30
Trial ID
NCT00983385
Treatments Being Tested
This was a single center, open-label, two-way crossover, drug-drug-interact...
Status
Completed
Location
J&JPRD Clinical Pharmacology Unit
Start Date
2005-09-28
Trial ID
NCT03979989
Treatments Being Tested